Michael A. Ihnat

5.4k total citations · 1 hit paper
98 papers, 4.4k citations indexed

About

Michael A. Ihnat is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael A. Ihnat has authored 98 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 25 papers in Organic Chemistry and 25 papers in Oncology. Recurrent topics in Michael A. Ihnat's work include Synthesis and biological activity (20 papers), Quinazolinone synthesis and applications (16 papers) and Advanced Glycation End Products research (8 papers). Michael A. Ihnat is often cited by papers focused on Synthesis and biological activity (20 papers), Quinazolinone synthesis and applications (16 papers) and Advanced Glycation End Products research (8 papers). Michael A. Ihnat collaborates with scholars based in United States, United Kingdom and France. Michael A. Ihnat's co-authors include Antonio Ceriello, Jessica E. Thorpe, Ludovica Piconi, Katherine Esposito, Dario Giugliano, Roberto Testa, Massimo Boemi, Aleem Gangjee, Joshua W. Hamilton and Linda A. Warnke and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Michael A. Ihnat

98 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

2008 987 citations Antonio Ceriello, Ludovica Piconi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Ihnat United States	34	1.4k	1.3k	559	466	465	98	4.4k
Michaël Thomas United States	40	2.0k 1.5×	524 0.4×	844 1.5×	430 0.9×	596 1.3×	166	5.4k
Józef Drzewoski Poland	34	1.5k 1.1×	779 0.6×	516 0.9×	107 0.2×	472 1.0×	137	3.8k
Tomoyuki Fujita Japan	36	2.0k 1.5×	401 0.3×	541 1.0×	236 0.5×	351 0.8×	152	4.7k
Jan‐Olof Jeppsson Sweden	33	1.7k 1.2×	1.5k 1.1×	523 0.9×	112 0.2×	411 0.9×	74	5.0k
Renliang Zhang United States	40	2.4k 1.7×	559 0.4×	846 1.5×	234 0.5×	287 0.6×	115	7.0k
Tomáš Vaisar United States	43	1.6k 1.2×	1.2k 0.9×	1.3k 2.2×	99 0.2×	311 0.7×	127	4.7k
Luigi Iuliano Italy	47	1.7k 1.2×	445 0.3×	1.7k 3.0×	530 1.1×	301 0.6×	133	5.7k
Wei Zhang China	47	2.9k 2.1×	601 0.5×	805 1.4×	197 0.4×	760 1.6×	316	6.8k
Sohvi Hörkkö Finland	46	2.2k 1.6×	601 0.5×	1.7k 3.0×	157 0.3×	238 0.5×	105	9.7k
Hans Glaumann Sweden	46	1.9k 1.4×	647 0.5×	1.4k 2.6×	215 0.5×	772 1.7×	210	7.3k

Countries citing papers authored by Michael A. Ihnat

Since Specialization

Citations

This map shows the geographic impact of Michael A. Ihnat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Ihnat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Ihnat more than expected).

Fields of papers citing papers by Michael A. Ihnat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Ihnat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Ihnat. The network helps show where Michael A. Ihnat may publish in the future.

Co-authorship network of co-authors of Michael A. Ihnat

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Ihnat. A scholar is included among the top collaborators of Michael A. Ihnat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Ihnat. Michael A. Ihnat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bai, Ruoli, et al.. (2021). Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure–activity relationship, in vitro and in vivo evaluation as antitumor agents. Bioorganic & Medicinal Chemistry Letters. 41. 127923–127923. 20 indexed citations

Sauer, Scott J., Damon R. Reed, Michael A. Ihnat, et al.. (2021). Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. Frontiers in Oncology. 11. 659963–659963. 45 indexed citations

Xiang, Weiguo, et al.. (2020). The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity. Bioorganic & Medicinal Chemistry. 29. 115887–115887. 6 indexed citations

Gallucci, Randle M., et al.. (2018). Geochemical characterization and renal cell toxicity of water-soluble extracts from U.S. Gulf Coast lignite. Environmental Geochemistry and Health. 41(2). 1037–1053. 7 indexed citations

Zaware, Nilesh, Roy L. Kisliuk, Anja Bastian, Michael A. Ihnat, & Aleem Gangjee. (2017). Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents. Bioorganic & Medicinal Chemistry Letters. 27(7). 1602–1607. 11 indexed citations

Hurst, Robert E., Paul Hauser, Youngjae You, et al.. (2015). Identification of novel drugs to target dormant micrometastases. BMC Cancer. 15(1). 404–404. 11 indexed citations

Zhang, Xin, Sudhir Raghavan, Michael A. Ihnat, et al.. (2014). The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. Bioorganic & Medicinal Chemistry. 22(14). 3753–3772. 43 indexed citations

Ihnat, Michael A., et al.. (2012). Hypoxia triggers a HIF‐mediated differentiation of peripheral blood mononuclear cells into osteoclasts. Orthodontics and Craniofacial Research. 15(1). 1–9. 41 indexed citations

Ihnat, Michael A., et al.. (2012). SOCS3 Modulates Interleukin-6R Signaling Preference in Dermal Fibroblasts. Journal of Interferon & Cytokine Research. 32(5). 207–215. 5 indexed citations

10.

Gangjee, Aleem, Ying Zhao, Michael A. Ihnat, et al.. (2012). Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents. Bioorganic & Medicinal Chemistry. 20(14). 4217–4225. 8 indexed citations

11.

Lin, Li, Brian Hutzen, Mingxin Zuo, et al.. (2010). Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells. Cancer Research. 70(6). 2445–2454. 197 indexed citations

12.

Gangjee, Aleem, Wěi Li, Lu Lin, et al.. (2009). Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors. Bioorganic & Medicinal Chemistry. 17(20). 7324–7336. 30 indexed citations

13.

Ihnat, Michael A., Jessica E. Thorpe, & Antonio Ceriello. (2007). Hypothesis: the "metabolic memory" - the new challenge of diabetes. Clinical Diabetology. 8(7). 289–294. 8 indexed citations

14.

Piconi, Ludovica, et al.. (2007). Evaluation of gliclazide ability to attenuate the hyperglycaemic ‘memory’ induced by high glucose in isolated human endothelial cells. Diabetes/Metabolism Research and Reviews. 24(4). 301–309. 33 indexed citations

15.

Saban, Ricardo, Michael R. D’Andrea, Patricia Andrade‐Gordon, et al.. (2007). Regulatory network of inflammation downstream of proteinase-activated receptors. BMC Physiology. 7(1). 3–3. 30 indexed citations

16.

Saban, Marcia R., Helen L. Hellmich, Cindy Simpson, et al.. (2007). Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. BMC Cancer. 7(1). 204–204. 20 indexed citations

17.

Ihnat, Michael A., et al.. (2005). Differential Antioxidant Response in ARPE–19 Cells and Human Retinal Pericytes in Response to Chronic High as Compared to Oscillating Normal/High Glucose Levels. Investigative Ophthalmology & Visual Science. 46(13). 416–416. 1 indexed citations

18.

Kamat, Chandrashekhar D., Dixy E. Green, Linda A. Warnke, et al.. (2005). Role of HIF Signaling on Tumorigenesis in Response to Chronic Low-Dose Arsenic Administration. Toxicological Sciences. 86(2). 248–257. 58 indexed citations

19.

Hurst, Robert E., Chandrashekhar D. Kamat, Kimberly D. Kyker, Dixy E. Green, & Michael A. Ihnat. (2004). A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel. Cancer Letters. 217(2). 171–180. 12 indexed citations

20.

Gangjee, Aleem, et al.. (2003). Antiangiogenic and antitumor agents. Bioorganic & Medicinal Chemistry. 11(23). 5155–5170. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact